Rhabdomyolysis is a rare but life-threatening complication of statin therapy. A 74-year-old man, treated with atorvastatin, developed rhabdomyolysis after the co-administration of fusidic acid and flucloxacillin. The patient recovered with supportive treatment and subsequently tolerated reintroduction of atorvastatin. Pharmacokinetic interactions can cause raised plasma statin concentrations, which can precipitate rhabdomyolysis in the presence of certain predisposing biological factors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/pgmj.2007.064097 | DOI Listing |
Publication Analysis
Top Keywords
fusidic acid
8
rhabdomyolysis
4
rhabdomyolysis atorvastatin
4
atorvastatin fusidic
4
acid rhabdomyolysis
4
rhabdomyolysis rare
4
rare life-threatening
4
life-threatening complication
4
complication statin
4
statin therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!